Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3633815017 | Prolonged-release suspension for injection | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3633816016 | Extended-release suspension for injection | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3633817013 | Prolonged-release suspension for injection (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | a une forme pharmaceutique (attribut) | True | Prolonged-release suspension for injection | Inferred relationship | Some | |
| Rilpivirine 300 mg/mL prolonged-release suspension for injection | a une forme pharmaceutique (attribut) | True | Prolonged-release suspension for injection | Inferred relationship | Some | |
| Product containing precisely paliperidone (as paliperidone palmitate) 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) | a une forme pharmaceutique (attribut) | True | Prolonged-release suspension for injection | Inferred relationship | Some | |
| Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection | a une forme pharmaceutique (attribut) | True | Prolonged-release suspension for injection | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR